Living a legacy of leading edge innovation
About our parent company
Since its founding over 40 years ago, medac GmbH has focused on developing treatments for autoimmune diseases and cancer for patients all over the world. Headquartered in Germany, medac GmbH has developed more than 60 different specialized therapies with worldwide marketing and distribution agreements. It is an industry leader that continually releases new and innovative drug products.